DexCom

YTD

ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.

CEO

Kevin Ronald Sayer

CEOKevin Ronald Sayer

Employees

10,300

Employees10,300

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1999

Founded1999

Employees

10,300

Employees10,300

DXCM Key Statistics

Market cap

29.59B

Market cap29.59B

Price-Earnings ratio

52.56

Price-Earnings ratio52.56

Dividend yield

—

Dividend yield—

Average volume

4.01M

Average volume4.01M

High today

$75.86

High today$75.86

Low today

$74.55

Low today$74.55

Open price

$75.05

Open price$75.05

Volume

1.50M

Volume1.50M

52 Week high

$93.25

52 Week high$93.25

52 Week low

$57.52

52 Week low$57.52

DXCM News

The Motley Fool 7h

If You'd Invested $1,000 in DexCom 10 Years Ago, Here's How Much You'd Have Today

The company's innovative devices have helped it generate decent performances. Shares of DexCom (DXCM 0.47%), a medical device specialist, have lagged the marke...

Simply Wall St 4d

DexCom: Assessing Valuation as Operational Gains Highlight Growth and Capital Efficiency

DexCom (DXCM) just reported some compelling figures that are likely to catch the eye of anyone keeping tabs on the healthcare tech space. The recent data shows...

Simply Wall St 6d

Will Rising Returns on Invested Capital Change DexCom's Global Growth Narrative?

In the past week, DexCom reported significant growth in return on capital employed, reaching 17% over five years, alongside a 29% increase in its capital base....

Analyst ratings

83%

of 29 ratings

Buy

82.8%

Hold

17.2%

Sell

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.